← Back
$AMLX All transactions

Amylyx Pharmaceuticals, Inc.

A

$ Value

$0

Shares

248,865

Price

$0

Filed

Mar 9

Insider

Name

Klee Justin B.

Title

Co-Chief Executive Officer

CIK

0001898314

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-05

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

3,583,481

Footnotes

The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. | 25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.

Filing Info

Accession No.

0001193125-26-098437

Form Type

4

Issuer CIK

0001658551

Klee Justin B.'s History

Date Ticker Type Value
2026-03-05 AMLX A $0
2026-03-05 AMLX A $0
2026-03-02 AMLX $424K
2026-02-02 AMLX $228K
2026-01-16 AMLX M $22K
2026-01-16 AMLX $28K
2026-01-16 AMLX M $0
2026-01-15 AMLX M $1.5M
2026-01-15 AMLX $1.8M
2026-01-15 AMLX M $0

Other Insiders at AMLX (90d)

Insider Bought Sold Last
FRATES JAMES M
Chief Financial Officer
$167K 2026-03-05
Bedrosian Camille L
Chief Medical Officer
$94K 2026-03-05
Klee Justin B.
Co-Chief Executive Officer
$651K 2026-03-05
Cohen Joshua B
Co-Chief Executive Officer
$652K 2026-03-05
Mazzariello Gina
Chief Legal Officer
$198K 2026-03-05